NCT07457918 2026-03-09
COVE-4
Verrica Pharmaceuticals Inc.
Phase 3 Not yet recruiting
Clinical Trials
7 trialsNCT07246590 2026-01-21
COVE-2
Verrica Pharmaceuticals Inc.
Phase 3 Recruiting
NCT05889845 2025-09-05
Candin for the Treatment of Common Warts
Nielsen BioSciences, Inc.
Phase 3 Completed
NCT00472459 2025-04-18
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
Galderma R&D
Phase 3 Completed
NCT03812510 2020-11-23
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Aclaris Therapeutics, Inc.
Phase 3 Completed
NCT03691831 2020-10-27
A Study of A-101 Topical Solution for the Treatment of Common Warts
Aclaris Therapeutics, Inc.
Phase 3 Completed
NCT03687372 2020-10-05
Study of A-101 Topical Solution for the Treatment of Common Warts
Aclaris Therapeutics, Inc.
Phase 3 Completed